Junia V Melo

A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.

Beth Wilmot, Shannon K McWeeney, Jennifer L. Snead, 2010, Blood.

Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia.

J. Melo, M. Mohty, J. Goldman, 2008, Blood.

The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.

J. Melo, M. Mohty, J. Apperley, 2007, Blood.

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

J. Melo, J. Goldman, J. Apperley, 2006, Blood.